ZERBAXA

This brand name is authorized in United States. It is also authorized in Austria, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Spain, Turkey, UK.

Active ingredients

The drug ZERBAXA contains a combination of these active pharmaceutical ingredients (APIs):

1	Ceftolozane UNII 7R247U84HY - CEFTOLOZANE SULFATE
	Ceftolozane belongs to the cephalosporin class of antimicrobials. Ceftolozane exerts bactericidal activity through binding to important penicillin-binding proteins (PBPs), resulting in inhibition of bacterial cell-wall synthesis and subsequent cell death.
	Read more about Ceftolozane
2	Tazobactam UNII UXA545ABTT - TAZOBACTAM SODIUM
	Tazobactam is a beta-lactam structurally related to penicillins. It is an inhibitor of many molecular Class A beta-lactamases, including CTX-M, SHV, and TEM enzymes.
	Read more about Tazobactam

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DI54		J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DI Other cephalosporins
Discover more medicines within J01DI54

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02446901
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	2658-MEE-0417
EE	Ravimiamet	1697351
ES	Centro de información online de medicamentos de la AEMPS	1151032001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	392550
FR	Base de données publique des médicaments	65166404
GB	Medicines & Healthcare Products Regulatory Agency	310081
HK	Department of Health Drug Office	65156
IL	מִשְׂרַד הַבְּרִיאוּת	8697
IT	Agenzia del Farmaco	044506018
JP	医薬品医療機器総合機構	6139506D1020
LT	Valstybinė vaistų kontrolės tarnyba	1078169
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	023M2017
NL	Z-Index G-Standaard, PRK	128430
NZ	Medicines and Medical Devices Safety Authority	17340
PL	Rejestru Produktów Leczniczych	100354781
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64654001
SG	Health Sciences Authority	15317P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699636261385
US	FDA, National Drug Code	67919-030